Large-scale testing (Phase 3)Study completedNCT02076815What this trial is testingAnagrelide Retard in Essential ThrombocythemiaWho this might be right forEssential Thrombocythemia AOP Orphan Pharmaceuticals AG 106
Testing effectiveness (Phase 2)Study completedNCT00413634What this trial is testingThe Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)Who this might be right forEssential Thrombocythaemia Shire 24
Not applicableStudy completedNCT01198717What this trial is testingPediatric Disease Registry in Essential Thrombocythaemia (ET)Who this might be right forEssential Thrombocythemia (ET) Shire 60
Early research (Phase 1)Ended earlyNCT04637009What this trial is testingTAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid NeoplasmsWho this might be right forAcute Myeloid LeukemiaMyeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm Astex Pharmaceuticals, Inc. 20
Early research (Phase 1)Study completedNCT03895112What this trial is testingMPN-RC 118 AVID200 in MyelofibrosisWho this might be right forPrimary MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Myelofibrosis+2 more John Mascarenhas 21
Testing effectiveness (Phase 2)Ended earlyNCT00931762What this trial is testingEvaluate Safety and Efficacy of Panobinostat in Participants With Primary MyelofibrosisWho this might be right forPrimary MyelofibrosisPost-Polycythemia VeraPost-Essential Thrombocytopenia Novartis Pharmaceuticals 35
Large-scale testing (Phase 3)Study completedNCT01259856What this trial is testingRandomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)Who this might be right forHigh Risk Polycythemia VeraHigh Risk Essential Thrombocythemia Ronald Hoffman 168
Large-scale testing (Phase 3)Study completedNCT02101268What this trial is testingEfficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MFWho this might be right forPrimary Myelofibrosis (PMF)Post-polycythemia Vera (Post-PV)Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Sierra Oncology LLC - a GSK company 156
Early research (Phase 1)Ended earlyNCT03373877What this trial is testingEvaluation of Ruxolitinib in Combination With PU-H71 for Treatment of MyelofibrosisWho this might be right forMyelofibrosisPrimary MyelofibrosisPost-polycythemia Vera Myelofibrosis+1 more Samus Therapeutics, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT01392443What this trial is testingAsian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MFWho this might be right forPrimary Myelofibrosis (MF)Post-Polycythemia Vera (PV) MFPost-Essential Thrombocythemia (ET) MF Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Ended earlyNCT02730884What this trial is testingSingle-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and AnemiaWho this might be right forLeukemiaMyelofibrosisAnemia+1 more M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT02577926What this trial is testingThe Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential ThrombocythemiaWho this might be right forPolycythemia Vera (PV)Essential Thrombocythemia (ET) RWTH Aachen University 207
Large-scale testing (Phase 3)Study completedNCT01214915What this trial is testingEffect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential ThrombocythaemiaWho this might be right forEssential Thrombocythemia (ET) Shire 53
Testing effectiveness (Phase 2)Study completedNCT02084563What this trial is testingStudy of Molecular and Genetic Abnormalities in Patients With Myeloid NeoplasmsWho this might be right forAcute Myeloid LeukemiaMyeloproliferative NeoplasmsMyelodysplastic Syndromes+1 more Hospital Israelita Albert Einstein 455
Not applicableStudy completedNCT05044026What this trial is testingA Prospective, Two-arm, Non-interventional Study of JAKAVI® (Ruxolitinib) in Patients With MyelofibrosisWho this might be right forPrimary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis Novartis Pharmaceuticals 1,012
Not applicableUnknownNCT03116542What this trial is testing18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential ThrombocythemiaWho this might be right forEssential ThrombocythemiaPrimary Myelofibrosis, Fibrotic StagePrimary Myelofibrosis, Prefibrotic Stage Hamad Medical Corporation 21
Testing effectiveness (Phase 2)Looking for participantsNCT06552429What this trial is testingPeginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ETWho this might be right forEssential Thrombocythemia Xiamen Amoytop Biotech Co., Ltd. 27
Testing effectiveness (Phase 2)Study completedNCT01981850What this trial is testingRO7490677 In Participants With MyelofibrosisWho this might be right forPrimary MyelofibrosisPolycythemia VeraPost-Essential Thrombocythemia Myelofibrosis Hoffmann-La Roche 125
Large-scale testing (Phase 3)Active Not RecruitingNCT06456346What this trial is testingBomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)Who this might be right forEssential Thrombocythemia Merck Sharp & Dohme LLC 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04446650What this trial is testingFedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)Who this might be right forPrimary Myelofibrosis Bristol-Myers Squibb 31